Jim Grady
Consultant
Jim Grady is a consultant at Back Bay Life Science Advisors. He has considerable experience working in immuno-oncology and across various therapeutic areas within the rare diseases space. During his career, Mr. Grady has supported a variety of projects that span business development and licensing, commercial strategy, search and evaluation, primary and secondary market research, startup operations, and financial analysis.
Before joining Back Bay, Mr. Grady worked in commercial and business development roles for Rallybio, a publicly traded rare disease-focused biotech, as a consultant for Boulder Biotech Launch Specialists, and as co-founder of IngenoVax, an immuno-oncology startup that had developed and patented a fully-synthetic cancer vaccine platform. Prior to his pivot to the biotech industry, Mr. Grady began his corporate career by working for several years as a Credit Analyst at CoBank, a large corporate lender.
Mr. Grady holds a BS in Chemical & Biological Engineering and a BS in Business Administration with an emphasis in Finance, both from University of Colorado Boulder. He also holds an MBA with emphasis in Corporate Finance & Consulting from University of Notre Dame.